Expression of the neurofibromatosis type 1 (NF1) gene during mouse embryonic development

Prog Brain Res. 1995:105:327-35. doi: 10.1016/s0079-6123(08)63311-7.

Abstract

The von Recklinghausen neurofibromatosis type 1 (NF1) gene was identified by positional cloning and found to be a tumor suppressor gene expressed most abundantly in brain. One isoform of NF1 (type 2 NF1) contains an additional 21 amino acids inserted into a region of the protein involved in the regulation of p21-ras. To study the role of the NF1 gene in mammalian development, the expression of the NF1 gene and protein product, neurofibromin, during mouse embryonic development was determined. NF1 mRNA and neurofibromin expression was detectable by Northern and Western analysis, respectively, after day 10 of murine embryogenesis and remained elevated throughout development. Type 2 NF1 mRNA expression predominated before day 10, after which time, type 1 (lacking the insertion) NF1 mRNA was the predominant isoform detected. The protein expression of the type 2 isoform was similar to overall neurofibromin expression by Western blot analysis with greatest expression in adult brain. Despite a similar tissue distribution pattern, type 2 neurofibromin was not found to be associated with brain cytoplasmic microtubules in the same fashion as the uninserted type 1 isoform. Collectively, these experiments suggest that the switch from type 2 to type 1 neurofibromin isoform predominance during embryogenesis may have significant functional consequences.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Embryo, Mammalian / physiology
  • Embryonic and Fetal Development / genetics
  • Fetal Proteins / biosynthesis
  • Gene Expression Regulation, Developmental / physiology*
  • Genes, Neurofibromatosis 1*
  • Gestational Age
  • Mice
  • Neurofibromin 1
  • Protein Biosynthesis

Substances

  • Fetal Proteins
  • Neurofibromin 1